Research Topics
| Rami B IbrahimSummaryAffiliation: Wayne State University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Drug removal by plasmapheresis: an evidence-based reviewRami B Ibrahim
Department of Pharmacy, Karmanos Cancer Institute, 4100 John R, Detroit, MI 48201 2013, USA
Pharmacotherapy 27:1529-49. 2007..Other considerations are the merits and pitfalls of the different methods used in published reports and recommendations for future pharmacokinetic studies in this field...
Effect of aprepitant on intravenous tacrolimus disposition in reduced intensity hematopoietic stem cell transplantationRami B Ibrahim
Department of Pharmacy Karmanos Cancer Hospital, 4100 John R, Detroit, MI 48201 2013, USA
J Oncol Pharm Pract 14:113-21. 2008..Collectively, these data suggest that AP effect on tacrolimus metabolism is of minor clinical significance. A controlled trial is needed to confirm these findings...- Influence of plasma exchange on the disposition of the fourth generation cephalosporin cefepimeRami B Ibrahim
Department of Pharmacy, Karmanos Cancer Institute, 4100 John R, Detroit, MI 48201 2013, USA
J Oncol Pharm Pract 15:217-22. 2009..96, r(2) = 0.92; p<0.05). The above results suggest that, under the studied conditions, cefepime removal by PE is clinically insignificant (approximately 4% of total 2 g dose)... - Nonabsorbable corticosteroids use in the treatment of gastrointestinal graft-versus-host diseaseRami B Ibrahim
Karmanos Cancer Institute and Wayne State University, Detroit, Michigan 48201, USA
Biol Blood Marrow Transplant 15:395-405. 2009..This review evaluates the current evidence of nonabsorbable corticosteroids in HSCT and sets forth recommendations for future trials with these agents... - Immediate cross-hypersensitivity between micafungin and caspofungin: a case reportShruti Patel
Wayne State University, Detroit, MI, USA
J Oncol Pharm Pract 15:187-9. 2009..It is recommended to avoid challenging patients with history of immediate hypersensitivity to one echinocandin with another... - Sirolimus-itraconazole interaction in a hematopoietic stem cell transplant recipientAhmed Said
Eugene Applebaum College of Pharmacy and Allied Health Professions, Wayne State University, Detroit, Michigan 48201, USA
Pharmacotherapy 26:289-95. 2006..Preemptive sirolimus dosage reduction and close monitoring of its whole blood trough levels are required whenever this combination is considered to avoid immunosuppressant toxicity in already critically ill patients... - Palifermin in a hematopoietic stem cell transplant patient with osteonecrosis of the jawLeah A Yageman
Eugene Applebaum College of Pharmacy and Allied Health Professions, Wayne State University, Detroit, MI 48201-2020, USA
J Oncol Pharm Pract 12:119-21. 2006..When contemplating palifermin as a mucosal protectant in a hematopoietic stem cell transplant patient with ONJ, a careful benefit-to-risk assessment is in order to ensure optimal effectiveness without undue harm... - The sulfone syndrome secondary to dapsone prophylaxis in a patient undergoing unrelated hematopoietic stem cell transplantationMuneer H Abidi
Division of Hematology and Oncology, Department of Pharmacy, Barbara Ann Karmanos Cancer Institute, Eugene Applebaum College of Pharmacy and Allied Health, Wayne State University, Detroit, Michigan 48201, USA
Hematol Oncol 24:164-5. 2006..We conclude that the clinical presentation of this patient after HSCT on dapsone therapy coincide with the sulfone syndrome not previously described in a patients after HSCT... - Systemic absorption of topical lidocaine in a bone marrow transplant recipient with hepatic sinusoidal obstruction syndromeBichoy H Gabra
Karmanos Cancer Institute, Detroit, MI, USA
Am J Health Syst Pharm 68:135-7. 2011..A case of systemic lidocaine exposure in a bone marrow transplant recipient with severe hepatic sinusoidal obstruction syndrome (SOS) receiving treatment with lidocaine patch 5% is reported... - Thalidomide for the treatment of histiocytic sarcoma after hematopoietic stem cell transplantMuneer H Abidi
Division of Hematology and Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan 48109, USA
Am J Hematol 82:932-3. 2007..Her disease recurred and thalidomide therapy was started, with her overall disease burden significantly reduced as measured radiographically... - Anti-thrombin III in the management of hematopoietic stem-cell transplantation-associated toxicityRami B Ibrahim
Karmanos Cancer Institute, Harper University Hospital, The Detroit Medical Center, 3990 John R, Detroit, MI 48201 2020, USA
Ann Pharmacother 38:1053-9. 2004..To describe the evidence assessing the use of anti-thrombin III (AT-III) in the management of toxicity associated with hematopoietic stem-cell transplantation (HSCT)-conditioning regimens... - Cross-reactivity between paclitaxel and hazelnut: a case reportDenise G Bukacel
Department of Pharmacy, Karmanos Cancer Center, Farmington Hills, MI 48334, USA
J Oncol Pharm Pract 13:53-5. 2007..The hazelnut allergy may not be a nut-protein allergy at all, but rather an allergy to the components of paclitaxel that reside in the hazelnut itself... - Dapsone-induced methemoglobinemia: a primer for cliniciansJames A Barclay
Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Allied Health Professions, Wayne State University, Detroit, MI, USA
Ann Pharmacother 45:1103-15. 2011..To present a comprehensive review of dapsone-induced methemoglobinemia and its management...